Beata Bode

2.1k total citations
65 papers, 1.5k citations indexed

About

Beata Bode is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Beata Bode has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 17 papers in Rheumatology. Recurrent topics in Beata Bode's work include Sarcoma Diagnosis and Treatment (19 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Cancer Genomics and Diagnostics (7 papers). Beata Bode is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Cancer Genomics and Diagnostics (7 papers). Beata Bode collaborates with scholars based in Switzerland, United States and Germany. Beata Bode's co-authors include Holger Moch, Christian W. A. Pfirrmann, Marco Zanetti, Juerg Hodler, Gabriela Studer, Alexander Knuth, Bruno Fuchs, Philip B. Schöttle, Bernard Mengiardi and Maries van den Broek and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Bone and Joint Surgery.

In The Last Decade

Beata Bode

65 papers receiving 1.4k citations

Peers

Countries citing papers authored by Beata Bode

Since Specialization

Citations

This map shows the geographic impact of Beata Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Bode more than expected).

Fields of papers citing papers by Beata Bode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beata Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Bode. The network helps show where Beata Bode may publish in the future.

Co-authorship network of co-authors of Beata Bode

This figure shows the co-authorship network connecting the top 25 collaborators of Beata Bode. A scholar is included among the top collaborators of Beata Bode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beata Bode. Beata Bode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preoperative Ultrahypofractionated Radiation Therapy for Soft Tissue Sarcomas: Low Rate of Wound Complications 2024 ·Advances in Radiation Oncology ·(unknown), Christoph Glanzmann, Bruno Fuchs, Beata Bode, Gabriela Studer	1
2	Transdisciplinary sarcoma care: a model for sustainable healthcare transformation 2024 ·Swiss Medical Weekly ·Bruno Fuchs, Beata Bode, (unknown), (unknown), (unknown), (unknown), Pietro Giovanoli, Stefan Breitenstein, Paul M. Schneider, Guido Schüpfer, Stefan Boes, Gabriela Studer	4
3	Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors 2023 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), Eva Karamitopoulou, Quentin Simon, Beata Bode, Marianne Tinguely	28
4	Quality of Sarcoma Care: Longitudinal Real-Time Assessment and Evidence Analytics of Quality Indicators 2022 ·Cancers ·(unknown), Gabriela Studer, Beata Bode, (unknown), (unknown), (unknown), Javier Martín‐Broto, Alessandro Gronchi, Jean‐Yves Blay, Axel Le Cesne, Bruno Fuchs	14
5	Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients 2018 ·Clinical Cancer Research ·Paulino Tallón de Lara, Virginia Cecconi, Stefanie Hiltbrunner, Hideo Yagita∥, Martina Friess, Beata Bode, Isabelle Opitz, Bart Vrugt, Walter Weder, Paul Stolzmann, Emanuela Felley‐Bosco, Rolf A. Stahel, Verena Tischler, Christian Britschgi, Davide Soldini, Maries van den Broek, Alessandra Curioni‐Fontecedro	44
6	RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward? 2014 ·Oncology ·Richard Cathomas, Christian Rothermundt, Beata Bode, Bruno Fuchs, Roger von Moos, (unknown)	35
7	Trauma-Induced Cutaneous Focal Mucinosis of the Mammary Areola: An Unusual Presentation 2014 ·SHILAP Revista de lepidopterología ·Werner Kempf, (unknown), Natalja Denisjuk, Beata Bode, Franco Rongioletti	10
8	Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature 2013 ·Clinical Cancer Research ·Anu Sharma, Beata Bode, Gabriela Studer, Holger Moch, Michał Okoniewski, Alexander Knuth, Lotta von Boehmer, Maries van den Broek	51
9	Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 Clone 2013 ·Journal of Thoracic Oncology ·Spasenija Savic, Beata Bode, Joachim Diebold, (unknown), Audrey Barascud, (unknown), Bruno Grilli, Michelle Herzog, Ellen C. Obermann, Lukas Bubendorf	76
10	Silver-enhanced In Situ Hybridization for Determination of EGFR Copy Number Alterations in Non–Small Cell Lung Cancer 2012 ·The American Journal of Surgical Pathology ·Marie-Angela Wulf, Beata Bode, Dieter R. Zimmermann, Kaspar Rufibach, Walter Weder, Holger Moch, Alex Soltermann, Verena Tischler	7
11	Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10 2011 ·PubMed ·Alex Soltermann, (unknown), Silvia Behnke, Martina Storz, Holger Moch, Beata Bode	6
12	Is Dynamic Gadolinium Enhancement Needed in MR Imaging for the Preoperative Assessment of Scaphoidal Viability in Patients with Scaphoid Nonunion? 2011 ·Radiology ·Olivio F. Donati, Marco Zanetti, Ladislav Nagy, Beata Bode, Andreas Schweizer, Christian W. A. Pfirrmann	43
13	Determination of the Her-2/neu Gene Amplification Status in Cytologic Breast Cancer Specimens Using Automated Silver-enhanced In-situ Hybridization (SISH) 2010 ·The American Journal of Surgical Pathology ·Florian Fritzsche, Peter K. Bode, Holger Moch, Glen Kristiansen, Zsuzsanna Varga, Beata Bode	27
14	Sclerosing Epithelioid Fibrosarcoma: Case Presentation and a Systematic Review 2008 ·Clinical Orthopaedics and Related Research ·Christian Ossendorf, Gabriela Studer, Beata Bode, Bruno Fuchs	49
15	The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT 2008 ·European Journal of Nuclear Medicine and Molecular Imaging ·Klaus Strobel, (unknown), Katrin D. M. Stumpe, Thomas F. Hany, Beata Bode, (unknown), Patrick Veit‐Haibach, Gustav K. von Schulthess, Juerg Hodler	52
16	Rare Cause of Dysphagy: Giant Polypoid Esophageal Well-Differentiated Liposarcoma 2007 ·Case Reports in Gastroenterology ·Ladislav Mica, (unknown), Beata Bode, (unknown), (unknown)	5
17	Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma 2006 ·Modern Pathology ·Beata Bode, Simona Frigerio, Silvia Behnke, (unknown), Bernhard Odermatt, Dieter R. Zimmermann, Holger Moch	33
18	PET-positive fibrous dysplasia - a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery 2006 ·Skeletal Radiology ·Klaus Strobel, Beata Bode, Didier Lardinois, Ulrich Exner	29
19	Total Sacrectomy and Reconstruction with Structural Allografts for Neurofibrosarcoma of the Sacrum 2005 ·Journal of Bone and Joint Surgery ·Kan Min, Norman Espinosa, Beata Bode, Gerhard Exner	9
20	New capability for remotely controlled excavation 1990 ·Transactions of the American Nuclear Society ·(unknown), Beata Bode, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact